Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Lung Cancer-From Mechanisms of Action and Risk Factors in Disease Onset to Management.

Cancers·2026
Same author

E-Health and M-Health in Obesity Management: A Systematic Review and Meta-Analysis of RCTs.

Nutrients·2025
Same author

Wine Consumption and Lung Cancer Risk: A Systematic Review and Meta-Analysis.

Nutrients·2025
Same author

Leucocyte Telomere Length and Lung Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies.

Cancers·2024
Same author

Health Outcomes Associated with Olive Oil Intake: An Umbrella Review of Meta-Analyses.

Foods (Basel, Switzerland)·2024
Same author

Effects of Phenols from Olive Vegetation Water on Mutagenicity and Genotoxicity of Stored-Cooked Beef Patties.

Antioxidants (Basel, Switzerland)·2024

Related Experiment Videos

Association Between Triglyceride-Glucose Index and Risk of Cancer: A Systematic Review and Meta-Analysis.

Roberto Fabiani1, Valentina Squadroni1, Patrizia Rosignoli1

  • 1Department of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.

Journal of Personalized Medicine
|May 26, 2026
PubMed
Summary

Higher triglyceride-glucose (TyG) index values are linked to increased cancer risk. This meta-analysis found a significant association between elevated TyG index and overall cancer incidence, highlighting its potential as a cancer risk indicator.

Keywords:
TyG indexcancer riskinsulin resistancemeta-analysissystematic reviewtriglyceride–glucose index

Related Experiment Videos

Area of Science:

  • Metabolic Syndrome and Cancer Epidemiology
  • Biomarker Research
  • Insulin Resistance Studies

Background:

  • The triglyceride-glucose (TyG) index is a validated indicator of insulin resistance.
  • While linked to T2DM, hypertension, and cardiovascular disease, its association with cancer risk is less understood.
  • This study investigates the relationship between the TyG index and various cancer types.

Purpose of the Study:

  • To quantitatively assess the association between the TyG index and the risk of developing different cancers.
  • To synthesize evidence from existing literature through meta-analysis.

Main Methods:

  • A systematic literature search was conducted across PubMed, Web of Science, and Scopus.
  • Studies were selected using the PICOS framework and quality assessed with the Newcastle-Ottawa Scale (NOS).
  • Meta-analysis employed random-effects models to calculate pooled risk estimates (RR, OR, HR) and weighted mean differences (WMD) for TyG index values.

Main Results:

  • Cancer patients exhibited significantly higher TyG index values compared to controls (WMD: 0.23).
  • A higher TyG index was associated with increased cancer risk, both as a categorical (OR 1.33) and continuous (OR 1.14) variable.
  • Increased risk was noted for gastrointestinal, gynecological, colorectal, breast, and gastric cancers, but not for endometrial, ovarian, prostate, lung, or esophageal cancers.

Conclusions:

  • Elevated TyG index values are associated with an increased risk of overall cancer.
  • The association with specific cancer sites requires further investigation due to limited study numbers.
  • Prospective cohort studies are recommended to validate these findings and clarify site-specific risks.